ONO Pharmaceutical Co. Ltd.

05/07/2024 | Press release | Distributed by Public on 05/06/2024 22:01

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb’s Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.